Maximize R&D value through portfolio strategy and management
We work with your teams to develop integrated perspectives on projects, therapeutic areas, and portfolios. In doing so, we identify clinical development options to maximize value and optimize the risks and commercial potential. We also support you in the sustainably optimized management of agile and crisp-functional decision-making processes.
Improve R&D efficiency through PipelineRefuel©
We work together to develop comprehensive transformation programs and activate R&D budget reserves for reinvestment in more innovation. Our 360-degree approach combines short-term interventions and long-term structural adjustments to expand the use of R&D resources.
Tap into external fields of innovation through PipelineRegenerate©
We work with you to open up external innovation and inorganic growth options to regenerate your R&D pipeline. In doing so, we focus on the joint development of complementary search field strategies and the optimization of your business development and licensing capabilities.
Maximize clinical development speed with PipelineAccelerate©
To survive in the race for market approval, we work with you to develop targeted interventions for sustainable acceleration along the entire clinical value chain. These include strategic and tactical measures at the portfolio level as well as at the program and study level with measurable speed improvements.
Leverage R&D modernization and digitalization potential with PipelineReinvent©
Modern pharmaceutical research and development takes full advantage of advanced data analytics, automation and robotics, and artificial intelligence. We help you initiate your R&D digital transformation and offer support for implementing individual use cases—from pilots to scaling and organizational anchoring.
Embed sustainability and CO2 neutrality in clinical development and in the product life cycle
Research and development must serve patients and the planet. We work with you to develop sustainability strategies that not only ensure the CO2 neutrality of your R&D activities, but also have the potential to optimize the entire clinical treatment pathway.